Aspen regains its swagger
With radically reduced debt and Covid vaccine manufacturing capability, Aspen has regained some of its former swagger
18 March 2021 - 05:00
Entrepreneur and Aspen founder Stephen Saad feels vindicated in his quest to expand and build the sterile capacity that allows him to produce Johnson & Johnson’s vaccine on the African continent.
Saad told investors during the pharma group’s first-half results webinar that its Gqeberha (formerly Port Elizabeth) production facility was built with vaccines in mind. As a result, no adjustments to the manufacturing site have been necessary, in contrast with other plants abroad that have had to retool their facilities to make Covid-19 vaccines...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.